Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity

NCT01086800 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT01086800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
August 31, 2012
Enrollment
318 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary artery disease, obstructive sleep apnea